Genomic alterations associated with resistance to EGFR monoclonal antibodies (mAb) in real-world patients with metastatic colorectal cancer (mCRC).

被引:0
|
作者
Klempner, Samuel J.
Quintanilha, Julia C. F. C. F.
Emmett, Matthew
Graf, Ryon
Schrock, Alexa Betzig
Tukachinsky, Hanna
Oxnard, Geoffrey R.
Myer, Parvathi
机构
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Fdn Med Inc, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Albert Einstein Canc Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
52
引用
收藏
页码:52 / 52
页数:1
相关论文
共 50 条
  • [1] Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
    Schulz, Martin S.
    Wolf, Sebastian
    Struck, Vera
    Thomas, Niklas
    Husman, Gabriele
    Zeuzem, Stefan
    Koch, Christine
    Trojan, Joerg
    Schnitzbauer, Andreas Anton
    Bechstein, Wolf Otto
    Waidmann, Oliver
    CANCERS, 2022, 14 (07)
  • [2] Results of monoclonal antibodies against EGFR-receptors application in patients with metastatic colorectal cancer (mCRC).
    Vladimirova, Liubov Yu
    Kit, Oleg Ivanovich
    Nikipelova, Elena A.
    Abramova, Natalya A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Receipt of Next-generation Genomic Sequencing among Patients with Metastatic Colorectal Cancer(mCRC) in a Real-World Cohort
    Markt, S. C.
    Schumacher, F. R.
    Booker, B.
    Rose, J.
    Cooper, G. S.
    Koroukian, S. M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (04) : 808 - 808
  • [4] Real-world treatment patterns and outcomes associated with bevacizumab (bev) in metastatic colorectal cancer (mCRC).
    Saverno, Kimberly
    Walker, Mark S.
    Hennessy, Daniel
    Dhawan, Ravinder
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Age-related real-world outcomes for patients (pts) with metastatic colorectal cancer (mCRC).
    Curtis, Melissa
    Nussbaum, Nathan Coleman
    Hamrick, Harvey J.
    Bennette, Caroline Savage
    Meropol, Neal J.
    Miksad, Rebecca A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] A real-world application of liquid biopsy (LB) in metastatic colorectal cancer (mCRC).
    Procaccio, Letizia
    Del Re, Marzia
    Crucitta, Stefania
    Gianfilippo, Giulia
    Daniel, Francesca
    Di Antonio, Veronica
    Gallimberti, Sara
    Munari, Giada
    Zanella, Giulia
    Alberti, Giulia
    Rizzato, Mario Domenico
    Rasola, Cosimo
    Maddalena, Giulia
    Prete, Alessandra Anna
    Bergamo, Francesca
    Zagonel, Vittorina
    Lonardi, Sara
    Danesi, Romano
    Fassan, Matteo
    Loupakis, Fotios
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
    Pietrantonio, Filippo
    Vernieri, Claudio
    Siravegna, Giulia
    Mennitto, Alessia
    Berenato, Rosa
    Perrone, Federica
    Gloghini, Annunziata
    Tamborini, Elena
    Lonardi, Sara
    Morano, Federica
    Picciani, Benedetta
    Busico, Adele
    Volpi, Chiara Costanza
    Martinetti, Antonia
    Battaglin, Francesca
    Bossi, Ilaria
    Pellegrinelli, Alessio
    Milione, Massimo
    Cremolini, Chiara
    Di Bartolomeo, Maria
    Bardelli, Alberto
    de Braud, Filippo
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2414 - 2422
  • [8] CLINICAL AND ECONOMIC BURDEN OF TOXICITIES ASSOCIATED WITH MONOCLONAL ANTIBODIES FOR METASTATIC COLORECTAL CANCER (MCRC)
    Burudpakdee, C.
    Zhao, Z.
    Trochlil, K.
    Gao, S.
    Munakata, J.
    Barber, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 198 - 198
  • [9] CLINICAL AND ECONOMIC BURDEN OF TOXICITIES ASSOCIATED WITH MONOCLONAL ANTIBODIES FOR METASTATIC COLORECTAL CANCER (MCRC)
    Burudpakdee, C.
    Zhao, Z.
    Trochlil, K.
    Gao, S. K.
    Munakata, J.
    Barber, B.
    VALUE IN HEALTH, 2010, 13 (07) : A252 - A252
  • [10] REAL-WORLD TREATMENT PATTERNS, SEQUENCING, AND UNMET NEED IN METASTATIC COLORECTAL CANCER (MCRC)
    Desai, K.
    Shao, C.
    Li, S.
    Hair, G. M.
    Liu, L.
    Jain, R.
    Amonkar, M.
    VALUE IN HEALTH, 2024, 27 (06) : S183 - S183